GC
CPRX

Globeflex Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Globeflex Capital’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-450,580
Closed -$11.2M – 408
2026
Q1 		$11.2M Buy
450,580
+158,372
+54% +$3.77M 1.69% 5
2025
Q4 		$6.82M Buy
292,208
+1,529
+0.5% +$34.1K 1.04% 22
2025
Q3 		$5.73M Sell
290,679
-7,408
-2% -$152K 0.88% 29
2025
Q2 		$6.47M Buy
298,087
+43,901
+17% +$1.04M 0.54% 43
2025
Q1 		$6.16M Buy
254,186
+59,400
+30% +$1.34M 0.57% 40
2024
Q4 		$4.07M Buy
194,786
+148,388
+320% +$3.19M 0.34% 72
2024
Q3 		$922K Sell
46,398
-182,386
-80% -$3.38M 0.09% 193
2024
Q2 		$3.54M Hold
228,784
– – 0.37% 65
2024
Q1 		$3.65M Hold
228,784
– – 0.36% 63
2023
Q4 		$3.85M Sell
228,784
-5,500
-2% -$75.2K 0.39% 64
2023
Q3 		$2.74M Sell
234,284
-62,212
-21% -$832K 0.32% 82
2023
Q2 		$3.98M Sell
296,496
-7,695
-3% -$111K 0.44% 66
2023
Q1 		$5.04M Sell
304,191
-44
-0% -$726 0.62% 37
2022
Q4 		$5.66M Sell
304,235
-58
-0% -$893 0.72% 32
2022
Q3 		$3.9M Sell
304,293
-222
-0.1% -$2.63K 0.67% 27
2022
Q2 		$2.13M Hold
304,515
– – 0.52% 39
2022
Q1 		$2.52M Hold
304,515
– – 0.51% 38
2021
Q4 		$2.06M Hold
304,515
– – 0.42% 55
2021
Q3 		$1.61M Sell
304,515
-306,592
-50% -$1.68M 0.35% 72
2021
Q2 		$3.51M Buy
611,107
+616
+0.1% +$3.18K 0.63% 23
2021
Q1 		$2.81M Buy
610,491
+234,284
+62% +$931K 0.51% 45
2020
Q4 		$1.26M Buy
+376,207
New +$1.26M 0.27% 121

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Globeflex Capital's CPRX Position: Q2 2026 in Review

Globeflex Capital sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 450,580 shares — an estimated $11.2M sold.

Globeflex Capital first reported a position in CPRX in Q4 2020 and held it in 22 quarters. The position peaked at $11.2M in Q1 2026. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Globeflex Capital reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Globeflex Capital sold 450,580 Catalyst Pharmaceutical shares in Q2 2026, an estimated $11.2M.
  • Globeflex Capital first reported a position in Catalyst Pharmaceutical in Q4 2020 and held it in 22 quarters.
  • Globeflex Capital's Catalyst Pharmaceutical position peaked at $11.2M in Q1 2026.
  • 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.